Treatment of metastatic colorectal carcinoma: Recent advances in use of fluorouracil: Postgraduate Medicine: Vol 86, No 6

Views

CrossRef citations to date

Altmetric

Preview

A method that improved response to treatment and survival rates for metastatic colorectal carcinoma could save thousands of lives, considering that 80,000 Americans die of this disease each year. Drs Treat and Joseph describe refinements in administration of fluorouracil (Adrucil) that are having a positive impact on this common metastatic lesion.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Treatment of metastatic colorectal carcinoma

Recent advances in use of fluorouracil

Information for

Open access

Opportunities

Help and information

Treatment of metastatic colorectal carcinoma

Recent advances in use of fluorouracil

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature